Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-07

Clinical Trial Update: Spectrophon LTD Glucometry Monitor Accuracy

View source ↗

Summary

Completed clinical trial assessing the accuracy of Spectrophon LTD glucometry monitor for glucose metabolism disorders and diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spectrophon LTD glucometry monitor (Spectrophon glucometer)

Snippet

Sponsor: Tirat Carmel Mental Health Center | Conditions: Glucose Metabolism Disorders, Diabetes Mellitus | Status: COMPLETED | Results posted: 2019-03-07